The Preeclampsia Diagnostics Market Share was valued at USD 1.07 Billion in 2022 and is expected to reach USD 1.24 Billion By 2030 and grow at a CAGR of 2.4% over the forecast period of 2023-2030.   

Preeclampsia Diagnostics Market is a rapidly growing sector in the healthcare industry, driven by the increasing prevalence of preeclampsia among pregnant women worldwide. Preeclampsia is a serious condition characterized by high blood pressure and damage to organs, typically occurring after 20 weeks of pregnancy. It poses significant risks to both the mother and the unborn baby, making early detection and timely intervention crucial.

The market for preeclampsia diagnostics is witnessing substantial growth due to several factors. Firstly, there is a growing awareness among healthcare professionals about the importance of early detection and management of preeclampsia. This has led to an increased demand for reliable diagnostic tools that can accurately identify women at risk.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/2993

Advancements in medical technology have also played a vital role in driving market growth. Innovative diagnostic methods such as biomarker-based tests, ultrasound imaging, and blood pressure monitoring devices have greatly improved the accuracy and efficiency of preeclampsia diagnosis.

Key Market Segmentation:

By Test Type

• Urine Analysis
• Blood Tests

By Product

• Equipment
• Supplies

By End User

• Hospitals
• Diagnostic facilities
• Speciality clinics
• others

Key players

The major Key players are Diabetomics Inc., PerkinElmer Inc., F. Hoffmann-La Roche Ltd. DRG Instruments GmbH, Metabolomic Diagnostics, Thermo Fisher Scientific Holdings Inc. Sera Prognostics Inc., Shuwen Biotechnologies Co. Ltd., Siemens Healthineers AG. Baxter (U.S.) and the final reports list additional participants.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

[email protected],

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com/